Is repeat transurethral resection effective and necessary in patients with T1 bladder carcinoma?
BACKGROUND
We investigated the efficacy and necessity of repeat transurethral resection (Re-TUR) in T1 bladder cancer.


METHODS
From September 2004 to September 2009, 62 patients with pathologically confirmed T1 bladder tumours were investigated. Re-TUR was routinely performed within 3-6 weeks following the initial resection. The pathological results of the Re-TUR were reviewed, and the risk of recurrence was investigated.


RESULTS
Of the 62 patients who underwent Re-TUR, 22 had a residual tumour pathologically. Visible residual tumours were detected in 9 patients (14.5%). The risk of having a residual tumour was directly correlated with the diameter of the initial tumour in T1 tumours (p = 0.007).


CONCLUSIONS
Upstaging to T2 of the disease led to radical cystectomy in 11.29% of the patients in our series. Re-TUR should be routinely performed on all patients, especially on patients with high-grade tumours and with tumour diameters greater than 3 cm in T1 bladder cancer.
Yucel
Mehmet
M
Department of Urology, Dumlupinar University Faculty of Medicine, Kütahya, Turkey. myucel75 @ gmail.com
Hatipoglu
Namik Kemal
NK
Atakanli
Cengiz
C
Yalcinkaya
Soner
S
Dedekarginoglu
Galip
G
Saracoglu
Ugur
U
Aras
Erol
E
D000368:Aged; D002277:Carcinoma / Q000601:surgery* / Q000628:therapy; D016022:Case-Control Studies; D015653:Cystectomy / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008495:Medical Oncology / Q000379:methods; D008875:Middle Aged; D011446:Prospective Studies; D012008:Recurrence; D012306:Risk; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000601:surgery* / Q000628:therapy; D013520:Urologic Surgical Procedures / Q000379:methods*